SCHEMBL248442

SCHEMBL248442

CCCc1nc2cc(F)ccc2cc1CCN

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.42
MPO P05164 3/20 0.40
HTR2A P28223 2/20 0.40
TRPM8 Q7Z2W7 1/20 0.40
TLR8 Q9NR97 5/20 0.39
HTR1A P08908 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.38
BACE1 P56817 1/20 0.36
TAAR1 Q96RJ0 3/20 0.33
HRH4 Q9H3N8 1/20 0.33
DHFR P00374 1/20 0.33
NPC1 O15118 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TERT O14746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL248441 0.77 HTR2C (0.37) HTR2ABACE1HRH4DHFR
SCHEMBL19331559 0.73 IDO1 (0.39) IDO1MPOHTR2ATRPM8TLR8
SCHEMBL19331494 0.72 DHODH (0.41) IDO1KMT2AATMTAAR1HTT
SCHEMBL19331478 0.71 TAAR1 (0.47) IDO1MPOHTR2ATRPM8KMT2A
SCHEMBL16585417 0.70 FERMT2 (0.37) IDO1MPOHTR2ATRPM8HTR1A
SCHEMBL4433283 0.70 KDM4E (0.43) IDO1KMT2ABACE1TAAR1
SCHEMBL14352666 0.69 IDO1 (0.46) IDO1MPOHTR2ATRPM8HTR1A
SCHEMBL28609423 0.69 TLR8 (0.54) TLR8KMT2AATM
SCHEMBL15320225 0.69 PIK3CD (0.43) NPC1HTTRAB9A
Ammonia Solution, Strong SCHEMBL9131397 0.68 TLR8 (0.53) TLR8KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588469-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY Amgen Inc. (US) 2013-05-08 EP disclosed
WO-2012003271-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY AMGEN INC. (US) 2012-01-05 WO disclosed